Safety and efficacy of everolimus (EVE) as second-line treatment in neuroendocrine neoplasms G3 (NEN G3): An AIO phase II study (EVINEC)

被引：1
|
作者：
Pavel, M. E. [1 ]
von Weikersthal, L. Fischer [2 ]
Kloeppel, G. [3 ]
Krause, K. [4 ]
Apostolidis, L. [5 ]
机构：
[1] Univ Klin Erlangen, Endocrinol Dept, Gastroenterol & Hepatol, Erlangen, Germany
[2] Klinikum St Marien Amberg, Onkolog Zentrum, Amberg, Germany
[3] Tech Univ Munich, Inst Pathol, Munich, Germany
[4] AIO Studien gGmbH, Project Management Dept, Berlin, Germany
[5] Natl Ctr Tumor Dis NCT, Dept Med Oncol, Heidelberg, Germany
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.717
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1184MO
引用
收藏
页码：S702 / S702
页数：1
相关论文
共 50 条
  • [21] Can the Efficacy of Etoposide-Platinum Chemotherapy Be Predicted by p53/pRb Status in Grade 3 Neuroendocrine Neoplasms (G3 NEN)?
    Lacombe, C.
    De Rycke, O.
    Chen, R.
    Colnot, N.
    Hentic, O.
    Cazes, A.
    Zalcman, G.
    Ruszniewski, P.
    Couvelard, A.
    Cros, J.
    de Mestier, L.
    NEUROENDOCRINOLOGY, 2020, 110 : 195 - 195
  • [22] Temozolomide in Grade 3 Neuroendocrine Neoplasms (G3 NENs): A Multicentre Retrospective Review
    Chan, D.
    Chan, J.
    Halfdanarson, T.
    Kunz, P.
    McGarrah, P.
    Raj, N.
    Reidy-Lagunes, D.
    Thawer, A.
    Whitman, J.
    Wu, Y. L.
    Singh, S.
    NEUROENDOCRINOLOGY, 2019, 108 : 145 - 145
  • [23] Treatment outcomes of patients with G3 neuroendocrine neoplasms Data from the German NET Registry
    Luecke, S.
    Fottner, C.
    Lahner, H.
    Jann, H.
    Zolnowski, D.
    Grabowski, P.
    Cremer, B.
    Quietzsch, D.
    Maasberg, S.
    Pape, U. F.
    Gress, T. M.
    Rinke, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 72 - 72
  • [24] PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
    Sorbye, Halfdan
    Kong, Grace
    Grozinsky-Glasberg, Simona
    ENDOCRINE-RELATED CANCER, 2020, 27 (03) : R67 - R77
  • [25] Efficacy of somatostatin analogues (SSA) in G3 neuroendocrine neoplasms - A comprehensive analysis among the SwissNET cohort
    Siebenhuner, A.
    Christ, E.
    Kollar, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 111 - 111
  • [26] Phase II study of mFOLFIRINOX efficacy as first and subsequent lines of advanced gastrointestinal neuroendocrine tumors G3 and neuroendocrine carcinomas therapy.
    Zhulikov, Yaroslav
    Evdokimova, Ekaterina
    Gorbunova, Vera
    Emelianova, Galina
    Markovich, Alla Anatolievna
    Kachmasova, Abidat
    Delektorskaya, Vera
    Kovalenko, Elena
    Gadzhieva, Kizler
    Artamonova, Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 659 - 659
  • [27] PRRT in high-grade digestive neuroendocrine neoplasms (NET G3 and NEC)
    Sorbye, Halfdan
    Kong, Grace
    Grozinsky-Glasberg, Simona
    Strosberg, Jonathan
    JOURNAL OF NEUROENDOCRINOLOGY, 2025, 37 (03)
  • [28] Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)
    Sorbye, Halfdan
    Baudin, Eric
    Borbath, Ivan
    Caplin, Martyn
    Chen, Jie
    Cwikla, Jaroslaw B.
    Frilling, Andrea
    Grossman, Ashley
    Kaltsas, Gregory
    Scarpa, Aldo
    Welin, Staffan
    Garcia-Carbonero, Rocio
    Arnold, Rudolf
    Bartsch, Detlef
    Baudin, Eric
    Bodei, Lisa
    Borbath, Ivan
    Capdevila, Jaume
    Caplin, Martyn
    Chen, Jie
    Costa, Frederico
    Lima, Regina
    Couvelard, Anne
    Cwikla, Jaroslaw B.
    Davies, Philippa
    de Herder, Wouter W.
    Falconi, Massimo
    Falkerby, Jenny
    Fazio, Nicola
    Ferone, Diego
    Frilling, Andrea
    Garcia-Carbonero, Rocio
    Glasberg, Simona
    Gorbunova, Vera
    Grossman, Ashley
    Hoersc, Dieter
    Jensen, Robert
    Kaltsas, Gregory
    Kloeppel, Guenter
    Tumors, Endocrine
    Knigge, Ulrich Peter
    Kos-Kudla, Beata
    Krejs, Guenter J.
    Krenning, Eric
    Kulke, Matthew
    Lamberts, Steven W. J.
    van Dijkum, Elisabeth Nieveen
    Manuel O'Connor, Juan
    O'Toole, Dermot
    Pape, Ulrich-Frank
    NEUROENDOCRINOLOGY, 2019, 108 (01) : 54 - 62
  • [29] Mutational Landscape of 109 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms G3
    Venizelos, A.
    Elvebakken, H.
    Perren, A.
    Hjortland, G.
    Sundlov, A.
    Svensson, J. B.
    Lothe, I
    Detlefsen, S.
    Garresori, H.
    Kersten, C.
    Knappskog, S.
    Sorbye, H.
    NEUROENDOCRINOLOGY, 2020, 110 : 53 - 53
  • [30] Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3
    Merola, Elettra
    Falconi, Massimo
    Rinke, Anja
    Staettner, Stefan
    Krendl, Felix
    Partelli, Stefano
    Andreasi, Valentina
    Gress, Thomas M.
    Pascher, Andreas
    Arsenic, Ruza
    Doglioni, Claudio
    Kaemmerer, Daniel
    Wiedenmann, Bertram
    Pavel, Marianne E.
    AMERICAN JOURNAL OF SURGERY, 2020, 220 (02): : 284 - 289
12345